PACS Group (NYSE:PACS – Get Free Report) and Amplifon (OTCMKTS:AMFPF – Get Free Report) are both mid-cap healthcare companies, but which is the better investment? We will compare the two businesses based on the strength of their earnings, risk, profitability, dividends, analyst recommendations, valuation and institutional ownership.
Analyst Recommendations
This is a summary of recent ratings and price targets for PACS Group and Amplifon, as reported by MarketBeat.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| PACS Group | 0 | 2 | 5 | 0 | 2.71 |
| Amplifon | 0 | 2 | 3 | 0 | 2.60 |
PACS Group presently has a consensus target price of $58.80, indicating a potential upside of 25.29%. Given PACS Group’s stronger consensus rating and higher possible upside, research analysts clearly believe PACS Group is more favorable than Amplifon.
Profitability
This table compares PACS Group and Amplifon’s net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| PACS Group | 4.85% | 29.55% | 5.23% |
| Amplifon | 3.01% | 15.03% | 4.29% |
Volatility & Risk
PACS Group has a beta of -0.08, indicating that its stock price is 108% less volatile than the S&P 500. Comparatively, Amplifon has a beta of 0.67, indicating that its stock price is 33% less volatile than the S&P 500.
Valuation & Earnings
This table compares PACS Group and Amplifon”s top-line revenue, earnings per share (EPS) and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| PACS Group | $5.29 billion | 1.40 | $191.54 million | $1.72 | 27.28 |
| Amplifon | $2.71 billion | 0.91 | $103.33 million | $0.37 | 30.30 |
PACS Group has higher revenue and earnings than Amplifon. PACS Group is trading at a lower price-to-earnings ratio than Amplifon, indicating that it is currently the more affordable of the two stocks.
Summary
PACS Group beats Amplifon on 10 of the 12 factors compared between the two stocks.
About PACS Group
PACS Group, Inc., through its subsidiaries, operates skilled nursing facilities and assisted living facilities in the United States. The company also provides senior care and independent facilities. It engages in the acquisition, ownership, and leasing of health care-related properties. The company was founded in 2013 and is based in Farmington, Utah.
About Amplifon
Amplifon S.p.A. engages in the distribution of hearing solutions and the fitting of customized products that help people rediscover various emotions of sound in Europe, the Middle East, Africa, the Americas, and the Asia Pacific. The company offers Ampli-easy, Ampli-connect, Ampli-energy, and Ampli-mini hearing devices. It also operates Ampli-care, a platform to deliver audiological care experience; and Amplifon App to manage the device functions in real-time directly from smartphone. Amplifon S.p.A. was founded in 1950 and is headquartered in Milan, Italy. Amplifon S.p.A.
Receive News & Ratings for PACS Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for PACS Group and related companies with MarketBeat.com's FREE daily email newsletter.
